A single center, randomized, double-blind, single dose, dose escalation, placebo-controlled design was used to evaluate the safety, tolerability, and pharmacokinetics of single dose administration of nifedipine hydrochloride capsules in healthy Chinese subjects

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: a748cf6492e43cf607978a6bca82e940127ddcf4
First added on: Apr 08, 2025